Event Schedule 2025

Program

PROGRAM AT GLANCE GLANCE

08:30

Welcome

Welcome to the conference! A road map for the day.

Dr Julie Wehbe

Psychiatrist, Director, ADHD-BED Integrated

08:45

The Pathophysiology of ADHD overlap with other psychiatric pathologies and ensuring holistic care.

This session aims to provide understanding of 
how the physiological basis of ADHD provides an 
insight into the modes of treatment and why, left 
undiagnosed and untreated, ADHD can manifest 
in other ways including treatment resistant 
depression.

Dr Martin Katzman

BSc, MD, FRCPC

Professor Richard Newton

MBChB, FRANZCP, MRCPsych

09:30

Prevalence and presentation: screening for ADHD and ED in General Practice.

It can be challenging to screen for patients for ADHD and then to ensure they are provided with access to the appropriate specialist for assessment and management. This session aims to provide GPs with a straightforward toolkit to check for possible ADHD in patients and the ensure they receive timely specialist input. Screening for co-morbid eating disorders will also be covered.

Dr Will Errington

General Practitioner, Medical Director, ADHD-BED Integrated

10:15

In the specialist’s rooms: evaluation, initial management of ADHD and what will be in the patient’s letter.

The process of ADHD assessment is complex and requires significant pre-work on behalf of the patient. This session will provide GPs with an insight into the process of ADHD assessment, what to look for in key elements of the assessment letter they will receive to ensure comprehensive implementation of the specialist’s plan, and the key steps in initial management. A short case will be discussed in smaller groups.

Dr Kieran Kennedy

Psychiatrist, BSc MBChB FRANZP

11:00

Break

11:30

Paediatric ADHD: diagnosis, management and building the support network.

Paediatric and adolescent patients with ADHD present to the assessing clinician with a further layer of complexity. This session will provide GPs with an insight into the process of ADHD diagnosis and management of younger patients and provide insights into when patients may be appropriate for co-management with their GP.

Dr Jacinta Coleman

MBBS (Hons) FRACP, Cert Child/Adol Psych

12:15

ADHD / ED in primary care: role of GPs, specialists and allied health in providing and integrated approach.

ADHD is often co-morbid with eating disorders, in particular Binge Eating disorder. This session will provide practical insight into how to manage patient with this diagnosis in primary care.

Professor Stephen Touyz

BSC, BSC (HONS.) PHD, FAED, FAPS

13:00

Lunch

13:45

My patient has been diagnosed with ADHD – where do I start with medication management?

Medical initiation can be a challenge for GPs with limited experience in the field from both clinical and regulatory standpoint. This presentation will provide a framework for medication initiation and monitoring, covering medication holidays, S8 psychostimulant up titration and switching and non-stimulant options with key review periods and clinical check-ins described. The initial case discussion will be extended to give concrete examples from current specialised general practice.

Dr Will Errington

General Practitioner, Medical Director, ADHD-BED Integrated

14:30

Beyond the basics: management of complex ADHD patients

Patients rarely present with a single issue and in an environment of increasing adult ADHD diagnoses patients often have more than one medical issue to manage. This session will provide guidance on managing more complex patients including those with hypertension and more significant mental health pathologies.

Dr Vicki Nahamkes

MBBS, FRACGP, ADHD-BED Integrated

15:15

Case presentation and delegate discussion: generating a holistic management plan for a patient and initiating medication.

This session will enable participants implement their learnings of the day to work together to generate a real-world management plan for a patient with a new diagnosis of ADHD

16:00

Break

16:30

ADHD S8 Medications: Legal and Regulatory Safeguarding

Prescribing the required medication to patients with ADHD can be complex: each state has different review and authority requirements. This session seeks to highlight the key legal and regulatory aspects of prescribing S8 psychostimulant medications in different jurisdictions to ensure safe practice for your patients.

Martin Bortros

Risk Advisor, Avant

17:00

Bringing it all together – case review, key take homes, latest research and what 2026 and onwards may bring

The case in the previous session will be discussed and the possible future direction of the rapidly evolving ADHD management and diagnosis environment outlined.

Dr Julie Wehbe

Psychiatrist, Director, ADHD-BED Integrated

Dr Will Errington

General Practitioner, Medical Director, ADHD-BED Integrated

17:30

End